カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

世界の尿検査市場（～2027）：製品別（尿試験紙、妊娠・受精キット、試薬、使い捨て型、自動型、半自動型、POC分析装置）、用途別、エンドユーザー別、検査種類別

◆英語タイトル：Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027

MarketsandMarketsが発行した調査報告書（MD3259-23）◆商品コード：MD3259-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年2月7日
◆ページ数：222
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

マーケット＆マーケット社の本調査資料では、世界の尿検査市場規模が2022年に39億ドルとなり、2028年までに57億ドルに達すると予測しています。さらに、予測期間中に年平均8.1%で拡大すると展望しています。本書では、尿検査の世界市場について詳しく分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（消耗品、計器）分析、検査種類別（妊娠・不妊検査、生化学検査、尿沈渣検査）分析、用途別（疾患スクリーニング、妊娠・不妊）分析、エンドユーザー別（診断検査機関、病院・診療所、在宅医療装置）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの項目を整理しています。また、Siemens Healthineers AG (Germany)、F. Hoffmann-La Roche Ltd. (Switzerland)、Cardinal Health、Inc. (US)、Abbott Laboratories (US)、Danaher Corporation (US)などの企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の尿検査市場規模：製品別
- 消耗品の市場規模
- 計器の市場規模
・世界の尿検査市場規模：検査種類別
- 妊娠・不妊検査の市場規模
- 生化学検査の市場規模
- 尿沈渣の市場規模
・世界の尿検査市場規模：用途別
- 疾患スクリーニングにおける市場規模
- 妊娠・不妊における市場規模
・世界の尿検査市場規模：エンドユーザー別
- 診断検査機関における市場規模
- 病院・診療所における市場規模
- 在宅医療装置における市場規模
・世界の尿検査市場規模：地域別
- 北米の尿検査市場規模
- ヨーロッパの尿検査市場規模
- アジア太平洋の尿検査市場規模
- 中南米の尿検査市場規模
- 中東・アフリカの尿検査市場規模
・競争状況
・企業情報

“The global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period.” Market growth is driven by factors such as increased production diagnostic products and government initiatives. On the other hand, challenges associated with urinalysis market like changing regulatory landscapes is the major factors hampering the growth of this market.
“The consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period”
The urinalysis market is segmented into consumables and instruments. In 2021, consumables segment accounted for the highest growth rate in the urinalysis market. Increase in number of research & development and product approval and increased focus on reducing diseases like kidney and liver disease cases which are also associated with age increased age are major factor contributing to the growth of this segment.

“The pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market, by test type, during the forecast period”
The urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. In 2021, pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market. Increasing funds for research, increasing awareness on fertility and pregnancy testing in women and increasing adoption of rapid pregnancy tests is major factor contributing to the growth of this segment.

“The disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period”
The urinalysis market is segmented into disease screening and pregnancy & fertility. In 2021, disease screening segment accounted for the highest growth rate in the urinalysis market. Increasing funding for the prevention of diseases like diabetes and Kidney diseases, growth in the number of diagnostic and imaging centers and improving healthcare infrastructure in emerging countries are major factor contributing to the growth of this segment.

“The diagnostic laboratories segment accounted for the highest growth in the urinalysis market, by end user, during the forecast period”
The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the highest growth rate in the urinalysis market. Emerging markets offer lucrative growth opportunities, growing number of regulatory approvals for diagnostic technologies and rising incidence of life style related disorders are major factors contributing to the growth of this segment.

“Asia Pacific: The fastest-growing region in urinalysis market”
The global urinalysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of diabetes and supportive government policies in the healthcare sector is driving the growth of the urinalysis market in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6% , and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:
• Siemens Healthineers AG (Germany)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Cardinal Health, Inc. (US)
• Abbott Laboratories (US)
• Danaher Corporation (US)
• Sysmex Corporation (Japan)
• Thermo Fisher Scientific, Inc. (US)
• Quidel Corporation (US)
• Becton, Dickinson and Company (US)
• Bio-Rad Laboratories, Inc. (US)
• EKF Diagnostics (UK)
Research Coverage:
This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.

❖ レポートの目次 ❖

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKETS COVERED 32
1.3.1 URINALYSIS MARKET SEGMENTATION 32
1.3.2 REGIONAL SCOPE 33
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 34
1.5 LIMITATIONS 34
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.2 RESEARCH APPROACH 36
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN 36
2.2.1 SECONDARY DATA 37
2.2.1.1 Key data from secondary sources 37
2.2.1.2 Activities involved in secondary research 38
2.2.2 PRIMARY DATA 38
2.2.2.1 Primary sources 38
2.2.2.2 Key data from primary sources 39
2.2.2.3 Key industry insights 40
2.2.2.4 Breakdown of primary interviews 41
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 41
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.3 MARKET SIZE ESTIMATION 42
2.3.1 BOTTOM-UP APPROACH 42
2.3.1.1 Approach 1: Company revenue estimation 43
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 43
2.3.1.2 Approach 2: Company presentations and primary interviews 43
2.3.1.3 CAGR projections 44
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
2.3.2 TOP-DOWN APPROACH 44
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH 44
2.4 DATA TRIANGULATION 45
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.5 MARKET SHARE ANALYSIS 46
2.6 STUDY ASSUMPTIONS 46
2.7 GROWTH RATE ASSUMPTIONS 46
2.8 RISK ASSESSMENT 47
2.8.1 RISK ASSESSMENT: URINALYSIS MARKET 47
2.9 RECESSION IMPACT 47
3 EXECUTIVE SUMMARY 49
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 49
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION) 49
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 50
FIGURE 11 URINALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 50
FIGURE 12 URINALYSIS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 51
4 PREMIUM INSIGHTS 52
4.1 URINALYSIS MARKET OVERVIEW 52
FIGURE 13 RISING ADOPTION OF POC DIAGNOSTICS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD 52
4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2022 VS. 2027 52
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 52
4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2022 VS. 2027 53
FIGURE 15 BIOCHEMICAL URINALYSIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD 53
4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2022 VS. 2027 53
FIGURE 16 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 53
4.5 URINALYSIS MARKET SHARE, BY END USER, 2022 VS. 2027 54
FIGURE 17 DIAGNOSTICS LABORATORIES TO ACCOUNT FOR DOMINANT MARKET SHARE DURING FORECAST PERIOD 54
4.6 URINALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES 54
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases to impact market 56
5.2.1.2 Rising geriatric population and age-associated diseases to fuel market growth 56
TABLE 1 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050) 57
5.2.1.3 Increasing adoption of POC urine diagnostic tests to drive market 57
5.2.2 RESTRAINTS 58
5.2.2.1 Availability of refurbished urine analyzers to pose challenges for market 58
5.2.2.2 High capital investments and lack of skilled laboratory technicians to restrain market growth 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Increasing investments in healthcare and life sciences to fuel growth in emerging markets 59
5.2.3.2 Technological advancements in urine analyzers to augment market growth 59
5.2.3.3 Increasing government initiatives and funding for preventive care to provide growth opportunities 60
5.2.4 CHALLENGES 60
5.2.4.1 Changing regulatory landscape to challenge market growth 60
6 URINALYSIS MARKET, BY PRODUCT 61
6.1 INTRODUCTION 62
TABLE 2 URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 62
6.2 CONSUMABLES 62
TABLE 3 URINALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 4 URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION) 63
6.2.1 PREGNANCY & FERTILITY KITS 63
6.2.1.1 Rapid accessibility and testing convenience to drive market 63
TABLE 5 URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2020–2027 (USD MILLION) 64
6.2.2 DIPSTICKS 64
6.2.2.1 Low cost and standard efficiency to increase use of dipsticks 64
TABLE 6 URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2020–2027 (USD MILLION) 65
6.2.3 DISPOSABLES 65
6.2.3.1 Urine collection cups to drive demand for disposables 65
TABLE 7 URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2020–2027 (USD MILLION) 66
6.2.4 REAGENTS 66
6.2.4.1 Increasing use of controls and calibrators to drive market growth 66
TABLE 8 URINALYSIS MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION) 67
6.3 INSTRUMENTS 67
TABLE 9 KEY PRODUCTS IN INSTRUMENTS SEGMENT 67
TABLE 10 URINALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 11 URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 68
6.3.1 AUTOMATED URINE ANALYZERS 68
TABLE 12 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 13 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 69
6.3.1.1 Integrated urine analyzers 69
6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers 69
TABLE 14 URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 70
6.3.1.2 Sediment urine analyzers 70
TABLE 15 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 16 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 71
6.3.1.2.1 Microscopy analyzers 71
6.3.1.2.1.1 Increased adoption of automated microscopy urine analyzers to drive market growth 71
TABLE 17 URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 71
6.3.1.2.2 Flow cytometry analyzers 72
6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption 72
TABLE 18 URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 72
6.3.1.3 Biochemical urine analyzers 72
6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market 72
TABLE 19 URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 73
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 73
6.3.2.1 Extensive use of semi-automated urine analyzers in hospitals & clinics to drive segment growth 73
TABLE 20 URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 74
6.3.3 POINT-OF-CARE URINE ANALYZERS 74
6.3.3.1 Need for rapid testing to drive demand for POC urine analyzers 74
TABLE 21 URINALYSIS MARKET FOR POC URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 75
7 URINALYSIS MARKET, BY TEST TYPE 76
7.1 INTRODUCTION 77
TABLE 22 URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 77
7.2 PREGNANCY & FERTILITY TESTS 77
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE SEGMENT GROWTH 77
TABLE 23 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2020–2027 (USD MILLION) 78
7.3 BIOCHEMICAL TESTS 78
TABLE 24 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 25 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2020–2027 (USD MILLION) 79
7.3.1 LABORATORY TESTS 79
7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market 79
TABLE 26 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2027 (USD MILLION) 80
7.3.2 POC TESTS 80
7.3.2.1 Convenience of POC testing to drive segment growth 80
TABLE 27 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2020–2027 (USD MILLION) 80
7.4 SEDIMENT URINALYSIS 81
7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET GROWTH 81
TABLE 28 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY TYPE, 2020–2027 (USD MILLION) 81
8 URINALYSIS MARKET, BY APPLICATION 82
8.1 INTRODUCTION 83
TABLE 29 URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
8.2 DISEASE SCREENING 83
TABLE 30 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 31 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020–2027 (USD MILLION) 84
8.2.1 URINARY TRACT INFECTIONS 84
8.2.1.1 Increasing prevalence of UTIs to drive segment growth 84
TABLE 32 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020–2027 (USD MILLION) 85
8.2.2 KIDNEY DISEASES 85
8.2.2.1 Rapidly growing geriatric population and prevalence of kidney diseases to fuel segment growth 85
TABLE 33 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020–2027 (USD MILLION) 86
8.2.3 DIABETES 86
8.2.3.1 Development of advanced analytical tools for diabetes to drive market growth 86
TABLE 34 URINALYSIS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION) 86
8.2.4 LIVER DISEASES 87
8.2.4.1 High prevalence of liver diseases to fuel segment growth 87
TABLE 35 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020–2027 (USD MILLION) 87
8.2.5 OTHER DISEASE SCREENING APPLICATIONS 87
TABLE 36 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 88
8.3 PREGNANCY & FERTILITY 88
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT 88
TABLE 37 URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2020–2027 (USD MILLION) 89
9 URINALYSIS MARKET, BY END USER 90
9.1 INTRODUCTION 91
TABLE 38 URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 91
9.2 DIAGNOSTIC LABORATORIES 91
9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET 91
TABLE 39 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 92
9.3 HOSPITALS & CLINICS 92
9.3.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE MARKET 92
TABLE 40 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 93
9.4 HOME CARE SETTINGS 93
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET 93
TABLE 41 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 94
9.5 RESEARCH LABORATORIES & INSTITUTES 94
9.5.1 DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET 94
TABLE 42 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 95
10 URINALYSIS MARKET, BY REGION 96
10.1 INTRODUCTION 97
TABLE 43 URINALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION) 97
10.2 NORTH AMERICA 97
FIGURE 20 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT 98
TABLE 44 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 45 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99
TABLE 46 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 47 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 48 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 49 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 50 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 100
TABLE 51 NORTH AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 52 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
TABLE 53 NORTH AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 54 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 102
10.2.1 RECESSION IMPACT 102
10.2.2 US 102
10.2.2.1 Rapid growth of geriatric population to drive market growth 102
TABLE 55 US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 103
TABLE 56 US: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 57 US: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 58 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 59 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 60 US: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 104
TABLE 61 US: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 62 US: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
TABLE 63 US: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 64 US: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 106
10.2.3 CANADA 106
10.2.3.1 Increasing prevalence of chronic diseases to augment market 106
TABLE 65 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 107
TABLE 66 CANADA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 67 CANADA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 68 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 69 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 70 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 108
TABLE 71 CANADA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 72 CANADA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109
TABLE 73 CANADA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 74 CANADA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 110
10.3 EUROPE 110
TABLE 75 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 76 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 77 EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 78 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 79 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 80 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 81 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 113
TABLE 82 EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 83 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 84 EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 85 EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 114
10.3.1 RECESSION IMPACT 114
10.3.2 GERMANY 115
10.3.2.1 Increasing healthcare expenditure to fuel market growth 115
TABLE 86 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 87 GERMANY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 88 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 89 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 90 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 91 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 117
TABLE 92 GERMANY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 93 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 94 GERMANY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 95 GERMANY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 118
10.3.3 UK 118
10.3.3.1 Rising government healthcare expenditure to propel market growth 118
TABLE 96 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 97 UK: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 98 UK: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 99 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 100 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 101 UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 120
TABLE 102 UK: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 103 UK: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 104 UK: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 105 UK: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3.4 FRANCE 122
10.3.4.1 High R&D expenditure to provide growth opportunities 122
TABLE 106 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 107 FRANCE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 108 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 109 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 110 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 111 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 124
TABLE 112 FRANCE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 113 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 114 FRANCE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 115 FRANCE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 125
10.3.5 ITALY 125
10.3.5.1 Large aging population to drive market growth 125
TABLE 116 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 126
TABLE 117 ITALY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 118 ITALY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 119 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 120 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 121 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 127
TABLE 122 ITALY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 123 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 124 ITALY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 125 ITALY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.6 SPAIN 129
10.3.6.1 Rising geriatric population to propel market 129
TABLE 126 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 127 SPAIN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 128 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 129 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 130 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 131 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 131
TABLE 132 SPAIN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 133 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 134 SPAIN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 135 SPAIN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 132
10.3.7 REST OF EUROPE 132
TABLE 136 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 133
TABLE 137 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 138 REST OF EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 139 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 140 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 141 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 134
TABLE 142 REST OF EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 143 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 144 REST OF EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 145 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 136
10.4 ASIA PACIFIC 136
FIGURE 21 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT 137
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 147 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138
TABLE 148 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 149 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 150 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 151 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 139
TABLE 153 ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 154 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 155 ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 156 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 141
10.4.1 RECESSION IMPACT 141
10.4.2 CHINA 141
10.4.2.1 Improving healthcare infrastructure in China to support market growth 141
TABLE 157 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142
TABLE 158 CHINA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 159 CHINA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 160 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 161 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 162 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 144
TABLE 163 CHINA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 164 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144
TABLE 165 CHINA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 166 CHINA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 145
10.4.3 JAPAN 145
10.4.3.1 Favorable regulatory framework to drive market growth 145
TABLE 167 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146
TABLE 168 JAPAN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 169 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 170 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 171 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 172 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 148
TABLE 173 JAPAN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 174 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 175 JAPAN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 176 JAPAN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 149
10.4.4 INDIA 149
10.4.4.1 Increasing investment in India’s healthcare system to drive market 149
TABLE 177 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 178 INDIA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 179 INDIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 180 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 181 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 182 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 151
TABLE 183 INDIA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 184 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 185 INDIA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 186 INDIA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 153
10.4.5 REST OF ASIA PACIFIC 153
TABLE 187 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 188 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 189 REST OF ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 190 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 191 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 192 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 155
TABLE 193 REST OF ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 194 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 195 REST OF ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 196 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
10.5 LATIN AMERICA 157
TABLE 197 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
TABLE 198 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 199 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 200 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 201 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 202 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 159
TABLE 203 LATIN AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 204 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 205 LATIN AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 206 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 160
10.5.1 RECESSION IMPACT 161
10.6 MIDDLE EAST & AFRICA 161
TABLE 207 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 161
TABLE 208 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 209 MIDDLE EAST & AFRICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 210 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 211 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 212 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 163
TABLE 213 MIDDLE EAST & AFRICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 214 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
TABLE 215 MIDDLE EAST & AFRICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 216 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 164
10.6.1 RECESSION IMPACT 165
11 COMPETITIVE LANDSCAPE 166
11.1 OVERVIEW 166
11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 166
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS 166
TABLE 217 STRATEGIES DEPLOYED BY KEY COMPANIES 166
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 168
FIGURE 22 REVENUE SHARE ANALYSIS OF TOP PLAYERS 168
11.4 MARKET SHARE ANALYSIS 169
11.4.1 URINALYSIS MARKET 169
FIGURE 23 URINALYSIS MARKET SHARE, BY KEY PLAYER (2021) 169
TABLE 218 URINALYSIS MARKET: DEGREE OF COMPETITION 169
11.5 COMPANY EVALUATION QUADRANT 170
11.5.1 LIST OF EVALUATED VENDORS 170
11.5.2 STARS 170
11.5.3 EMERGING LEADERS 170
11.5.4 PERVASIVE PLAYERS 171
11.5.5 PARTICIPANTS 171
FIGURE 24 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 171
11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021) 172
11.6.1 PROGRESSIVE COMPANIES 172
11.6.2 STARTING BLOCKS 172
11.6.3 RESPONSIVE COMPANIES 172
11.6.4 DYNAMIC COMPANIES 172
FIGURE 25 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021 173
11.7 COMPETITIVE BENCHMARKING 174
11.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS 174
FIGURE 26 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF LEADING PLAYERS 174
TABLE 219 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 174
TABLE 220 COMPANY PRODUCT FOOTPRINT 174
TABLE 221 COMPANY REGIONAL FOOTPRINT 175
11.8 COMPETITIVE SCENARIO 175
11.8.1 PRODUCT LAUNCHES AND APPROVALS 175
TABLE 222 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS 175
11.8.2 DEALS 176
TABLE 223 KEY DEALS 176
12 COMPANY PROFILES 177
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 177
12.1.1 SIEMENS HEALTHINEERS AG 177
TABLE 224 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 177
FIGURE 27 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021) 178
12.1.2 F. HOFFMANN-LA ROCHE LTD. 180
TABLE 225 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 180
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021) 181
12.1.3 CARDINAL HEALTH, INC. 183
TABLE 226 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 183
FIGURE 29 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022) 184
12.1.4 ABBOTT LABORATORIES 186
TABLE 227 ABBOTT LABORATORIES: BUSINESS OVERVIEW 186
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 187
12.1.5 DANAHER CORPORATION 189
TABLE 228 DANAHER CORPORATION: BUSINESS OVERVIEW 189
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 190
12.1.6 SYSMEX CORPORATION 192
TABLE 229 SYSMEX CORPORATION: BUSINESS OVERVIEW 192
FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022) 192
12.1.7 THERMO FISHER SCIENTIFIC, INC. 194
TABLE 230 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 194
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 195
12.1.8 QUIDEL CORPORATION 197
TABLE 231 QUIDEL CORPORATION: BUSINESS OVERVIEW 197
FIGURE 34 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021) 198
12.1.9 BECTON, DICKINSON AND COMPANY 200
TABLE 232 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 200
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 201
12.1.10 BIO-RAD LABORATORIES, INC. 202
TABLE 233 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 202
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 203
12.1.11 EKF DIAGNOSTICS 204
TABLE 234 EKF DIAGNOSTICS: BUSINESS OVERVIEW 204
FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021) 205
12.2 OTHER PLAYERS 206
12.2.1 ARKRAY, INC. 206
TABLE 235 ARKRAY, INC.: COMPANY OVERVIEW 206
12.2.2 ACON LABORATORIES, INC. 207
TABLE 236 ACON LABORATORIES, INC.: COMPANY OVERVIEW 207
12.2.3 77 ELEKTRONIKA KFT. 208
TABLE 237 77 ELEKTRONIKA KFT.: COMPANY OVERVIEW 208
12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD. 209
TABLE 238 URIT MEDICAL ELECTRONIC GROUP CO., LTD.: COMPANY OVERVIEW 209
12.2.5 DIRUI INDUSTRIAL CO., LTD. 210
TABLE 239 DIRUI INDUSTRIAL CO., LTD.: COMPANY OVERVIEW 210
12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 211
TABLE 240 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 211
12.2.7 BIOBASE GROUP 212
TABLE 241 BIOBASE GROUP: COMPANY OVERVIEW 212
12.2.8 ERBA MANNHEIM 213
TABLE 242 ERBA MANNHEIM: COMPANY OVERVIEW 213
12.2.9 ALPHATEC SCIENTIFIC 213
TABLE 243 ALPHATEC SCIENTIFIC: COMPANY OVERVIEW 213
12.2.10 TECO DIAGNOSTICS 214
TABLE 244 TECO DIAGNOSTICS: COMPANY OVERVIEW 214
12.2.11 ANALYTICON BIOTECHNOLOGIES AG 215
TABLE 245 ANALYTICON BIOTECHNOLOGIES AG: COMPANY OVERVIEW 215
12.2.12 BIOWAY BIOTECHNOLOGY 216
TABLE 246 BIOWAY BIOTECHNOLOGY: COMPANY OVERVIEW 216
12.2.13 HIGH TECHNOLOGY, INC. 216
TABLE 247 HIGH TECHNOLOGY, INC.: COMPANY OVERVIEW 216
12.2.14 AGAPPE DIAGNOSTICS 217
TABLE 248 AGAPPE DIAGNOSTICS: COMPANY OVERVIEW 217
12.2.15 GENRUI BIOTECH, INC. 217
TABLE 249 GENRUI BIOTECH, INC.: COMPANY OVERVIEW 217
12.2.16 SPINREACT S.A. 218
TABLE 250 SPINREACT S.A.: COMPANY OVERVIEW 218
12.2.17 DIALAB GMBH 218
TABLE 251 DIALAB GMBH: COMPANY OVERVIEW 218
12.2.18 QUANTIMETRIX CORPORATION 219
TABLE 252 QUANTIMETRIX CORPORATION: COMPANY OVERVIEW 219
12.2.19 BIOCARE CORPORATION 220
TABLE 253 BIOCARE CORPORATION: COMPANY OVERVIEW 220
12.2.20 RANDOX LABORATORIES LTD. 220
TABLE 254 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW 220
12.2.21 PZ CORMAY SA 221
TABLE 255 PZ CORMAY SA: COMPANY OVERVIEW 221
12.2.22 YD DIAGNOSTICS 222
TABLE 256 YD DIAGNOSTICS: COMPANY OVERVIEW 222
12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD. 222
TABLE 257 CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 222
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 223
13.1 DISCUSSION GUIDE 223
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
13.3 CUSTOMIZATION OPTIONS 229
13.4 RELATED REPORTS 229
13.5 AUTHOR DETAILS 230



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の尿検査市場（～2027）：製品別（尿試験紙、妊娠・受精キット、試薬、使い捨て型、自動型、半自動型、POC分析装置）、用途別、エンドユーザー別、検査種類別(Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 世界の鍼術用針市場：種類別（使い捨て型、非使い捨て型）、持ち手材料別、エンドユーザー別、地域別
  • 臨床化学分析装置の世界市場予測（～2028）：製品別、検査種類別、エンドユーザー別、地域別
  • 世界の超音波ニードルガイド市場：種類別（再利用型、使い捨て型）、用途別、エンドユーザー別
  • 世界の超音波プローブカバー市場：種類別（使い捨て型、再利用型）、素材別、用途別、エンドユーザー別、地域別
  • 世界のラテラルフローアッセイ市場（～2027）：製品別（キット、リーダー）、用途別、技術別、エンドユーザー別

    • ◆H&Iグローバルリサーチのお客様（例）◆